Monitor for actual execution of the sale via subsequent Form 4 filings. If 5AM Ventures completes this sale, it could mark the start of a distribution phase, potentially weighing on the stock. Given the stock's historical volatility, traders should watch for further insider selling or additional 144 filings from other affiliates.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 31 $6.79entry
- T+1 · 4mo ago +6.92%α +5.50% · $7.26
- T+5 · 3mo ago +1.18%α −2.33% · $6.87
- T+20 · 3mo ago +3.09%α +0.10% · $7.00
- T+60 · 22d ago −30.04%α −32.50% · $4.75
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
5AM Ventures V, L.P., an early venture investor and affiliated stockholder of Entrada Therapeutics, filed a Form 144 notice of intent to sell 331,156 shares of common stock, valued at approximately $2.17 million. The proposed sale represents about 0.85% of shares outstanding and signals potential portfolio distribution by a long-term holder.
Key Facts
- 5AM Ventures V, L.P. proposes to sell 331,156 shares of Entrada Therapeutics common stock.
- Estimated market value of the proposed sale is $2,169,072.
- Shares were acquired on October 12, 2016 via venture financing investment.
- The sale is to be executed through Goldman Sachs & Co. LLC.
- Filing date is July 30, 2026; the sale is not yet completed.
Financial Impact
Proposed sale of 331,156 shares (~0.85% of 38.8M shares outstanding) valued at ~$2.17M, representing a modest but notable reduction by a key early investor.
Risk Factors
- Further selling by 5AM Ventures or other early investors could increase supply and pressure the stock.
- The intent-to-sell filing may signal reduced confidence from a long-term holder, potentially spooking retail and institutional investors.
- Entrada Therapeutics is a small-cap biotech with volatile price action; the sale could amplify downside moves.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (TRDA), Batch item 1 | 0001674324-26-000006 |
| Document: 0001674324-26-000006-index.html | 0001674324-26-000006 |
| Document: 0001674324-26-000006.txt | 0001674324-26-000006 |
| 144 Filing (TRDA), Batch item 4 | 0001674324-26-000006 |
| Document: 0001674324-26-000006-index.html | 0001674324-26-000006 |
| Document: 0001674324-26-000006.txt | 0001674324-26-000006 |
Track record
21 reports on TRDA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
- Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
- Sep 9, 20269w ago Insider Cluster Bearish 6/10 Entry $6.42 Now $5.00 +22.12% settles Dec 4
- Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers